key: cord-0713716-vru2tb9b
authors: Allwood, Brian W; Koegelenberg, Coenraad F; Ngah, Veranyuy D; Sigwadhi, Lovemore N.; Irusen, Elvis M; Lalla, Usha; Yalew, Anteneh; Tamuzi, Jacques L; Allister, Marli Mc; Zemlin, Annalise E.; Jalavu, Thumeka P; Erasmus, Rajiv; Chapanduka, Zivanai C.; Matsha, Tandi E.; Fwemba, Isaac; Zumla, Alimuddin; Nyasulu, Peter S.
title: Predicting COVID-19 outcomes from clinical and laboratory parameters in an intensive care facility during the second wave of the pandemic in South Africa
date: 2022-04-01
journal: IJID Regions
DOI: 10.1016/j.ijregi.2022.03.024
sha: 08a37376762d2bbf86f3154b1379f7f625174c6c
doc_id: 713716
cord_uid: vru2tb9b

Background The second wave of COVID-19 in South Africa was caused by the Beta variant of SARS-CoV-2. This study aimed to explore clinical and biochemical parameters that could predict COVID-19 patients’ outcome. Methods We conducted a prospective study between 05 November 2020 and 30 April 2021 among confirmed COVID-19 patients admitted to the intensive care unit (ICU) of a tertiary hospital. We used cox proportional hazards model in Stata 16 to assess the risk factors associated with discharge or death. Those factors with p< 0.05 were considered statistically significant. Results We found a significantly ‘low median pH (p<0.001)’, ‘increased median arterial partial pressure of carbon dioxide (p<0.001)’, ‘elevated “D-dimer (p=0.003)’, ‘‘elevated ‘Troponin T (p=0.003)’, ‘N-terminal (NT)-prohormone BNP (p=0.010)’, and ‘C-reactive protein (p = 0.013)’” among COVID-19 patients who died as opposed to those who were discharged. An increased HCO3std was associated with a lower risk of death (HR 0.96, 95%CI: 0.93-0.99). Conclusions The mortality of COVID-19 patients admitted to ICU was associated with elevated D-dimer and TropT, low HCO3std. In addition, patients who died had a shorter duration of ICU stay. Large studies are warranted to increase identification of patient at risk of poor prognosis and improve clinical approach.

The novel coronavirus disease 2019 (COVID- 19) pandemic has caused over 472 million cases with 6,09 million deaths worldwide as of March 24 th A study of the second wave in Vietnam reported that fewer older people with a mean age of 46 years and that more females were infected (Nong et al., 2021) . Comparative studies of the first and second waves found a variation in the difference in mortality between the first two waves. While some studies show that the second wave had more incident cases than the first wave, including static numbers of intensive care unit (ICU) admission and deaths (Coccia, In Africa, as of the 31st of December 2020, 40 countries were already experiencing their second wave with the continent reporting a mean of 23790 daily new cases for epidemiological week 53 (Salyer et al., 2021) . South Africa was the most severely affected African country with over 80000 deaths by the end of December 2020, experiencing the start of the second wave in October 2020 (Frean, 2021) . The Western Cape, Eastern Cape, and KwaZulu-Natal provinces were most affected by the second wave, with the Western Cape Province reaching peak infection levels higher than that of the first wave (Tegally et al., 2021; Frean, 2021) . A national analysis of data from the daily hospital surveillance (DATCOV) national active surveillance system for COVID-19 hospitalisations concurred, as it showed that individuals hospitalised in the second wave were more likely to be older; more than 40 years, and less likely to have comorbidities (Jassat et al., 2021) . It concluded that there was a higher incidence of positive cases, an increase in hospitalization, and increased in-hospital mortality in the second wave, compared to the first wave (Jassat et al., 2021) . Identification of specific clinical and laboratory biomarkers of high mortality risk may improve decision-making for COVID-19 management in clinical practice. We conducted a prospective study between 05

November 2020 and 30 April 2021, of patients with COVID-19 admitted to the ICU to define clinical features and laboratory biomarkers associated with an increased risk of mortality in COVID-19 patients admitted in the ICU at a tertiary hospital in the Western Cape Province during the second wave in South Africa.

The study was conducted at Tygerberg Hospital, a 1380-bed tertiary hospital in Cape Town. The hospital provides tertiary services to approximately 3.5 million people from the Western Cape Province. Much of the population serviced by the hospital are from low-income areas, with a significant proportion living in low-cost and informal settlements where overcrowding, shared ablution and water facilities make social distancing and the advocated hygiene methods difficult. The study population comprised all consecutive patients admitted to the adult ICU between 05 November 2020 to 30 April 2021, when the database was censored. Over the course of the pandemic, the ICU's capacity fluctuated.

According to provincial guidelines, patients referred to the ICU were triaged by the consultants on duty based on disease severity and likely prognosis, and admissions were contingent on bed availability (CCSSA, 2021).

Data were captured prospectively each day using photographs of bedside clinical notes, which were securely stored electronically. Clinical data were remotely entered by a datacapturer into the Redcap® database, while laboratory results were also imported from the National Health Laboratory Services (NHLS) into the database. The data was quality checked by the 'data entry supervisor' to ensure that the information entered was of high quality and reliable.

Data collected included sociodemographic (age, sex, socio-economic status); clinical disease characteristics, pre-existing comorbidities (hypertension, diabetes, cardiovascular disease (CVD), chronic lung disease, obesity, and Human Immunodeficiency Virus (HIV)); routinely collected laboratory data; mode of respiratory support and management strategy. The primary outcome of interest was the proportion of patients who died after admission in the ICU, including those who were discharged from ICU and those who died in hospital. Time to death or censored (alive at discharge) was also assessed.

Continuous variables were expressed as median with inter-quartile range for skewed data. Categorical variables were expressed using frequencies and percentages. A multivariable model was developed for demographics, comorbidities, drugs, clinical symptoms, and bio-chemical parameters using variables strongly associated with mortality or survival outcomes at univariable analysis. The comparison between mortality and survival used the Pearson χ2 test or Fisher exact test where appropriate for categorical variables, and the Wilcoxon's rank-sum test for continuous variables. Factors associated with death or survival at p-value < 0.05 in unadjusted univariable were considered as statistically significant. To compare the survival functions for each sociodemographic, clinical, and biochemical covariate, the log-rank test, and the Wilcoxon test were used. Hazard ratios (HRs) were calculated using Cox's proportional hazards model to assess the risk factors associated with discharge and death. All statistical analyses were performed using Stata (V.16, Stata Corp, College Station, Texas, USA) statistical software.

In this cohort, 82 patients were admitted to the ICU from 5 November to April 2021.

Among them, 27 (33%) were males. Table 1 compared patient characteristics among those who died or survived while admitted to ICU. The median age (IQR) of those who were discharged was not significantly different from those who died: 50.4 (39.9-60.5) vs 55.2 (47.2-58.1), (p = 0.497). Underlying comorbidities were hypertension (48%), diabetes mellitus (41%), HIV (11%), hyperlipidemia (6%), and asthma (2%) ( Table 1 ).

The median duration of stay in ICU was 12 days (IQR: 8-17) days. The most common clinical features at presentation included fever (30%) and myalgia (29%) ( Table 1 ).

The median pH was 0.07 lower among those who died than discharged patients (p<0.001), whereas the median PaCO2 was 0.95 kPa higher among those who died (p<0.001) ( Table 1 ). Comparing the D-dimer between patients who died and those who Table   1 ).

The multivariate Cox proportional hazard model was performed to assess the relationship between various covariates and patients' survival or the risk of death. Data shows that elevated D-dimer levels were associated with increased risk of mortality in ICU (HR 1.05, 95%CI 1.00. -1.11); and elevated HCO3std level were associated with lower risk of mortality (HR 0.96, 95% CI 0.93-0.99). Furthermore, an increased lymphocyte count was associated with an increased in probability of being discharged (HR 1.10, 95%CI 1.02-1. 19 ). However, data showed no significant risk of mortality associated with an increased level of TropT (HR 1.00, 95%CI 1.00-1.01) ( Table 2 ).

The current study, conducted during South Africa's "second wave," found that COVID-19 patients admitted to ICU who died during the second COVID-19 wave had significantly elevated "D-dimer, TropT, NT-proBNP, CRP, and PaCO2" and low pH levels compared to those who were discharged from ICU during the second wave of the pandemic. In contrast there were no significant differences, none of the clinical features or comorbidities were associated with the risk of death in the ICU. showing that discharged patients were somewhat alkalotic (7.48). This is likely due to increased respiratory rate from COVID-19 pneumonia. The study has several limitations. The study had a relatively small sample and was observational in nature and some of the clinical features and co-morbidities were reported as unknown. It was a single-center study and external validity is required to support the widespread use of our findings. In addition, a larger sample size might improve the statistical power of the study. However, our findings have significant implications for a better understanding of clinical presentations of COVID-19 severity in the ICU during the second wave.

In summary, this study found that demographic, clinical, and co-morbidity variables were not significantly associated with mortality among COVID-19 patients admitted to the ICU during the second wave. However, mortality was associated with the D-dimer, TropT and

HCO3std. In addition, those who died had a shorter duration of ICU stay than those who survived. These findings may help development of a possible risk score to improve the identification of patients at high risk of mortality in the ICU and improve clinical decisionmaking in medical practice. All authors read and approved the final manuscript.

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

The authors have no conflict of interest in this work. 

Correlating arterial blood gas, acid-base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients

Pulmonary Embolism and Increased Levels of D-Dimer in Patients with Coronavirus Disease

Diagnosis and prediction of COVID-19 severity: can biochemical tests and machine learning be used as prognostic indicators?

The impact of first and second wave of the COVID-19 pandemic in society: comparative analysis to support control measures to cope with negative effects of future infectious diseases

COVID-19 and its implications for thrombosis and anticoagulation

Critical Care Society of Southern Africa. Allocation of scarce critical care resources during the COVID-19 pandemic health emergency in South Africa

Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series

Venous blood gas analysis in patients with COVID-19 symptoms in the early assessment of virus positivity

Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions

SARS-CoV-2 variants and ending the COVID-19 pandemic

COVID-19 second wave in South Africa. National Institute of Communicable Diseases

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a metaanalysis

Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

COVID-19 second wave mortality in Europe and the United States

Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa

Insufficient hyperfibrinolysis in COVID-19: a systematic review of thrombolysis based on meta-analysis and meta-regression. medRxiv

The role of biomarkers in diagnosis of COVID-19 -a systematic review

Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review

Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19

Rescue fibrinolysis in suspected massive pulmonary embolism during SARS-CoV-2 pandemic

Natriuretic peptides in heart failure: atrial and B-type natriuretic peptides

SARS-CoV-2 Viral Variants-Tackling a Moving Target

The second wave of COVID-19 in a tourist hotspot in Vietnam

N-terminal pro-B-type natriuretic peptide and longterm mortality in acute coronary syndromes

Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications

The 20 first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study

Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus

Prediction of COVID-19 severity using laboratory findings on admission: informative values, thresholds, ML model performance

Role of C-Reactive Protein at Sites of Inflammation and Infection

Emergence of a new SARS-CoV-2 variant in the UK

Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK

Detection of a SARS-CoV-2 variant of concern in South Africa

C-reactive protein levels in the early stage of COVID-19

World Health Organization. WHO Coronavirus (COVID-19) Dashboard

Emergence of a novel SARS-CoV-2 variant in Southern California

Associations of D-Dimer on Admission and Clinical Features

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis with Meta-Regression

NTProBNP: N-terminal pro b-type natriuretic peptide, CRP: C-reactive protein, paCO2: partial pressure of carbon dioxide, pH: potential hydrogen, PaO2: partial pressure of oxygen, PaCO2: partial pressure of carbon dioxide, SaO2: Arterial oxygen saturation

P-value computed without considered of unknowns and for smoking status past and current smoker considered as one group